Recurrent Mixed Cellularity Classical Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent Mixed Cellularity Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT03077828) | Northwestern University | 2017-04-21 |
Track Recurrent Mixed Cellularity Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.